Following the adoption of the Artificial Intelligence Act (“AI Act”) by the EU, the clock is now ticking for MedTech/BioTech providers/manufacturers whose portfolio incorporates an artificial intelligence system or a software including an AI system. A new, challenging field has opened up with increased remediation and implementation.
It is vital for impacted stakeholders to fully understand the degree of applicability of the Act’s requirements and to adjust their processes accordingly.
Contact Evnia if you need support to navigate through your AI Act regulatory journey!
Download Evnia’s white paper: AI Impact on MedTech – Evnia.
